Living and dying with chronic obstructive pulmonary disease

被引:122
作者
Lynn, J
Ely, EW
Zhong, ZS
McNiff, KL
Dawson, NV
Connors, A
Desbiens, NA
Claessens, M
McCarthy, EP
机构
[1] George Washington Univ, Ctr Improve Care Dying, Washington, DC USA
[2] Vanderbilt Univ, Med Ctr, Dept Med, Div Allergy Pulm & Crit Care, Nashville, TN USA
[3] Metrohlth Med Ctr, Div Gen Internal Med, Cleveland, OH USA
[4] Univ Virginia, Dept Med, Charlottesville, VA USA
[5] Univ Tennessee, Coll Med, Dept Med, Chattanooga Unit, Chattanooga, TN USA
[6] Marshfield Med Clin, Palliat Care Program, Marshfield, WI USA
[7] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA USA
关键词
COPD; emphysema; quality of life; outcomes; end of life; dysnea; artificial respiration;
D O I
10.1111/j.1532-5415.2000.tb03147.x
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
OBJECTIVE: To characterize chronic obstructive pulmonary disease (COPD) over patients' last 6 months of life. STUDY DESIGN: A retrospective analysis of a prospective cohort from the Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments (SUPPORT). SETTING: Hospitalization for exacerbation of COPD at five US teaching hospitals. PARTICIPANTS: COPD patients who died within 1 year (n = 416) among 1016 enrolled. METHODS: Interview and medical record data were organized into time windows beginning with death and ending 6 months earlier. OUTCOME MEASURES: Days in hospital, prognosis, illness severity, function, symptoms, patients' preferences, and impacts on families. RESULTS: One-year survival was 59%, 39% had greater than or equal to 3 comerbidities, and 15 to 25% of the patients' last 6 months were in hospitals. Exacerbation etiologies included respiratory infection (47%) and cardiac problems (30%). Better quality of life predicted longer survival (ARR: 0.36; 95% CI, 0.19-0.87) as did heart failure etiology of exacerbation (ARR: 0.57; CI, 0.40, 0.82). Estimates of survival by physicians and by prognostic model were well calibrated, although patients with the worst prognoses survived longer than predicted. Patients' estimates of prognosis were poorly calibrated. One-quarter of patients had serious pain throughout, and two-thirds had serious dyspnea. Patients' illnesses had a major impact on more than 25% of families. Patients' preferences for Do-Not-Resuscitate orders increased from 40% at 3 to 6 months before death to 77% within 1 month of death; their decisions not to use mechanical ventilation increased from 12 to 31%, and their preferences for resuscitation decreased from 52 to 23%. CONCLUSIONS: Patients with advanced COPD often die within :1 year and have substantial comorbidities and symptoms. Adequate description anchors improved care.
引用
收藏
页码:S91 / S100
页数:10
相关论文
共 45 条
[11]   The distribution of costs of care in mechanically ventilated patients with chronic obstructive pulmonary disease [J].
Ely, EW ;
Baker, AM ;
Evans, GW ;
Haponik, EF .
CRITICAL CARE MEDICINE, 2000, 28 (02) :408-413
[12]   Chronic obstructive pulmonary disease stage and health-related quality of life [J].
Ferrer, M ;
Alonso, J ;
Morera, J ;
Marrades, RM ;
Khalaf, A ;
Aguar, MC ;
Plaza, V ;
Prieto, L ;
Antó, JM .
ANNALS OF INTERNAL MEDICINE, 1997, 127 (12) :1072-1079
[13]  
FREEBORN N, 2000, J AM GERIATR SOC S, V48
[14]  
HIGGINS MW, 1998, CHEST, V96, P328
[15]  
HIGGINS MW, 1990, CLIN EPIDEMIOLOGY CH
[16]   A BRIEF SELF-ADMINISTERED QUESTIONNAIRE TO DETERMINE FUNCTIONAL-CAPACITY (THE DUKE ACTIVITY STATUS INDEX) [J].
HLATKY, MA ;
BOINEAU, RE ;
HIGGINBOTHAM, MB ;
LEE, KL ;
MARK, DB ;
CALIFF, RM ;
COBB, FR ;
PRYOR, DB .
AMERICAN JOURNAL OF CARDIOLOGY, 1989, 64 (10) :651-654
[17]  
HODGKIN JE, 1990, CLIN CHEST MED, V11, P555
[18]   Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease [J].
Hosenpud, JD ;
Bennett, LE ;
Keck, BM ;
Edwards, EB ;
Novick, RJ .
LANCET, 1998, 351 (9095) :24-27
[19]  
HUDSON L D, 1989, American Review of Respiratory Disease, V140, pS19
[20]   ACUTE HYPERCAPNIC RESPIRATORY-FAILURE IN PATIENTS WITH CHRONIC OBSTRUCTIVE LUNG-DISEASE - RISK-FACTORS AND USE OF GUIDELINES FOR MANAGEMENT [J].
JEFFREY, AA ;
WARREN, PM ;
FLENLEY, DC .
THORAX, 1992, 47 (01) :34-40